Explore Microdosing GLP-1 options here
So maybe I'll sort of ask it this way: of the cardiovascular, dementia, addiction all the sort of potential other uses what do you think is the most promising and the most probabilistic when we think about how these mechanisms are working
Summary: Rybelsus (semaglutide) is an oral GLP-1 receptor agonist that improves blood glucose control in adults with type 2 diabetes by stimulating insulin secretion, suppressing glucagon, and slowing gastric emptying
As Lilly continues to roll out results from the remaining seven Phase 3 trials in the program throughout 2026, the industry focus will remain on the long-term benefit-risk profile across various metabolic comorbidities
Critically, GH itself has limited direct anabolic effect
Complete the free assessment first, then review the introductory Med listing only after confirming clinical eligibility, included services, and the next charge